SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-002294
Filing Date
2022-01-06
Accepted
2022-01-06 21:00:24
Documents
2
Period of Report
2022-01-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4126
2 POA DOCUMENT poa.txt EX-24 4037
  Complete submission text file 0001209191-22-002294.txt   9506
Mailing Address C/O AMARIN PHARMA, INC. 1430 ROUTE 6 BEDMINSTER NJ 07921
Business Address
THERO JOHN F (Reporting) CIK: 0001199637 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41201 | Film No.: 22516311

Mailing Address 200 CLARENDON STREET, 6TH FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 6TH FLOOR BOSTON MA 02116 8445311834
CinCor Pharma, Inc. (Issuer) CIK: 0001868734 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences